Skip to main content

Table 2 Immunohistochemical staining for primary tumors and metastatic site

From: Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer

 

Wnt3a

Wnt5a

β-catenin

MMP-9

VEGFR-2

Primary tumor

51 (61.4%)

58 (69.9%)

70 (84.3%)

45 (54.2%)

30 (36.1%)

Metastatic site

38 (45.8%)

39 (47.0%)

44 (53.0%)

28 (33.7%)

22 (26.5%)

Concordance rate

79.4%

76.2%

79.4%

68.3%

40.0%